InvestorsHub Logo
Followers 610
Posts 15907
Boards Moderated 3
Alias Born 10/01/2000

Re: sundoctor post# 3506

Thursday, 03/24/2022 3:28:52 AM

Thursday, March 24, 2022 3:28:52 AM

Post# of 3516
Based on our probability adjusted DCF model that
takes into account potential future revenues from TSC
in select hypoxia-related indications, DFFN is valued at
$2.00/share. This model is highly dependent upon the
continued clinical success of TSC and will be adjusted
accordingly based upon future clinical results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DFFN News